Efforts to streamline referrals, diagnosis, treatment, and prior authorization, alongside artificial intelligence (AI) tools, ...

In an inception cohort (n=180; 2110 person-years), lung cancer incidence yielded an overall age-standardized SIR of 5.1, ...

The unapproved market existed before, but it has exploded since FDA-approved peptides became widely used around 2021, Varney ...

Qualitative interviews with 18 representatives from 14 Medicare Advantage organizations and 5 care management companies ...

What are your final takeaways from this panel discussion? Led by the moderator, the panelists examined the core lessons from ...

Nobel Prize in Medicine honors optogenetics pioneers who turn algae light-sensing protein into neural switches, transforming ...

Besides the expansion of anti-amyloid prescribing access, how do you envision Alzheimer's disease care changing over the next ...

The IDSA's first-ever complicated UTI guideline redefines the condition around systemic risk factors and severity, reflecting two decades of shifting resistance patterns, expanding indications, and ...

Medicare's Transforming Episode Accountability Model is projected to save $46.6 million by 2030, with safety-net hospitals ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Employer-mandated high-deductible health plan enrollment was not associated with reduced use of oral targeted anticancer ...

Evidence-Based Oncology ™ is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.